Monday, February 26, 2007

Dicey Situation: Can compulsive gamblers help themselves?

Bob now confesses that he is a gambler - a compulsive gambler - a compulsive gambler in recovery.
From: www.delcotimes.com

Saturday, February 24, 2007

China locks up online "addicts" for harsh rehab

Techniques for drug addiction and alcoholism are used at military-run clinics for youth who spend a lot of their time on the Internet.
From: seattletimes.nwsource.com

Wednesday, February 21, 2007

Understanding Genetic Factors Could Contribute To Better Smoking-Cessation Therapies

Americans are bombarded with antismoking messages, yet at least 65 million of us continue to light up. Genetic factors play an important role in this continuing addiction to cigarettes, suggest scientists at Washington University School of Medicine in St. Louis. [click link for full article]
From: www.medicalnewstoday.com

Tuesday, February 20, 2007

New Research May Overturn Conventional Wisdom On Drug-resistant Tuberculosis

A newly released study suggests that the majority of cases of drug-resistant tuberculosis (TB) among patients undergoing treatment for the disease may be due to new infections, not acquired resistance. If confirmed in future studies the research, in the March 15 issue of the Journal of Infectious Diseases, may drive a major shift in strategy for controlling TB.
From: www.sciencedaily.com

Drug Controls High-altitude Illness

Acetazolamide, a drug used to manage fluid retention in heart failure, controlled the serious effects of pulmonary edema, the accumulation of fluid in lung tissue from high altitude, as well as improved brain oxygenation, during a randomized, double-blind and placebo-controlled study.
From: www.sciencedaily.com

Saturday, February 17, 2007

Addiction And The Brain -- Are We Hard-wired To Abuse Drugs?

EVENT: At the 2007 annual meeting of the American Association for the Advancement of Science (AAAS), which took place on February 15, 2007 a panel of world-renowned neuroscientists presented recent advances in brain-imaging that have revolutionized our understanding of addiction as a chronic disease. The addiction symposium was sponsored by the U.S. [click link for full article]
From: www.medicalnewstoday.com

Friday, February 16, 2007

Former skinhead accused in robbery spree

Steven M. Stroud, 38, is accused of robbing three restaurants in January and earlier this month. A man who worked with him said Stroud was diagnosed with cancer and used heroin to cope with medical treatments.
From: www.katu.com

Jeffrey Wilkins, M.D., Named Inaugural Chair in Addiction Medicine at January 24 Ceremony

Addiction Medicine expert Jeffrey N. Wilkins, MD, vice chair of the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center, was named the inaugural Lincy Foundation/Andrew Heyward-Amy Moynihan Endowed Chair in Addiction Medicine at a ceremony on January 24. The Chair will fund research and teaching efforts focused on the causes and treatments for addiction.
From: www.newswise.com

Wednesday, February 14, 2007

Studies identify DNA regions linked to nicotine dependence

Americans are bombarded with antismoking messages, yet at least 65 million of us continue to light up. Genetic factors play an important role in this continuing addiction to cigarettes, suggest scientists at Washington University School of Medicine in St. Louis.
From: www.eurekalert.org

Catalyst Pharmaceutical Partners, Inc. Strengthens Scientific Advisory Board With Appointment of Richard A. Rawson, ...

CORAL GABLES, Fla., Feb. 14 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, ( Nachrichten ) Inc. today announced that it has appointed Dr. Richard Rawson to its Scientific Advisory Board, bringing the Board to seven members.
From: www.finanznachrichten.de

Tuesday, February 13, 2007

NIDA Meeting Focuses on Pain and Addiction

The National Institute on Drug Abuse plans to bring researchers and clinicians together for a two-day meeting to discuss "Pain, Opioids, and Addiction: An Urgent Problem for Doctors and...
From: alcoholism.about.com

The 2007 Healthcare Business Market Research Handbook Is an Indispensable Tool Designed To Help You Manage and Expand ...

DUBLIN, Ireland----Research and Markets has announced the addition of The 2007 Healthcare Business Market Research Handbook to their offering.
From: biz.yahoo.com

Speaker debunks myths about disorders

Six myths regarding anxiety and depression were all debunked Saturday. In front of about 500 people, Anne Andrews, assistant professor of molecular toxicology, corrected misconceptions about anxiety, depression and the effects of serotonin on the brain as it functions in these disorders.
From: www.collegian.psu.edu

Monday, February 12, 2007

Hooked By Genes: Studies Identify DNA Regions Linked To Nicotine Dependence

Americans are bombarded with antismoking messages, yet at least 65 million of us continue to light up. Genetic factors play an important role in this continuing addiction to cigarettes, suggest scientists at Washington University School of Medicine in St. Louis. In two studies in the January 2007 issue of Human Molecular Genetics, the scientists show that certain genetic variations can influence ...
From: www.sciencedaily.com

New Forecasting Tool Could Reduce Drug Development Costs

It now costs more than $800 million to develop a new drug. But what if pharmaceutical companies could predict which experimental drugs will ultimately get FDA approval, and which will ultimately fail? Researchers present a forecasting model that could potentially save hundreds of millions of dollars per new drug. They also urge more data sharing by the drug industry to improve the accuracy of ...
From: www.sciencedaily.com

Saturday, February 10, 2007

After A Stroke, Some Lose The Urge To Smoke

Intrigued by a patient whose two-pack-a-day smoking habit disappeared abruptly after he suffered a stroke, California researchers have discovered that a silver dollar-sized structure in the brain is a key controller of addictive cravings.
From: www.nwaonline.net

Embera NeuroTherapeutics, Inc. Closes Series A Funding, Starting FDA Trial Process

Embera NeuroTherapeutics, Inc., a start-up company developing novel treatments for a broad range of addictions, as well as other neuropsychiatric disorders, has secured over $800,000 of Series A financing that will help the company move its novel combinational drug into Phase 1b FDA trials. (PRWeb Feb 8, 2007) Post Comment:Trackback URL: ...
From: prweb.com

Glaxo and the Making of a Blockbuster Drug

Centient Biotech Investor submits: GlaxoSmithKline announced results yesterday. As expected, there was plenty of good news. Sales are brisk. Profit was up 5%. And among those numbers was a once little known drug, called Requip, that is now performing spectacularly well.
From: biz.yahoo.com

Prescription Weight-Loss Drug Orlistat Approved For Over-the-Counter Sales

The Food and Drug Administration (FDA) has approved orlistat capsules as an over-the-counter (OTC) weight loss aid for overweight adults. Orlistat helps produce weight loss by decreasing the intestinal absorption of fat.
From: www.sciencedaily.com

Scientists give a shot in the arm to the fight against smoking, drug abuse, and obesity

When Rachel Harrison was 16 years old, she took a drag from her first cigarette. She remembers loving it right away?the taste, the warmth, and especially the lightheaded rush that smoking gave her.
From: www.sciencenews.org